![Ryohei Yamamoto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ryohei Yamamoto
Directeur/Membre du Conseil chez Titan, Inc. (Japan)
Profil
Mr. Ryohei Yamamoto is on the Board of Directors at Tella Pharma, Inc., Titan, Inc. (Japan), and tella, Inc.
Postes actifs de Ryohei Yamamoto
Sociétés | Poste | Début |
---|---|---|
Titan, Inc. (Japan)
![]() Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | 01/05/2013 |
Anciens postes connus de Ryohei Yamamoto
Sociétés | Poste | Fin |
---|---|---|
TELLA, INC. | Directeur Administratif | 13/06/2012 |
Tella Pharma, Inc.
![]() Tella Pharma, Inc. Medical SpecialtiesHealth Technology Founded in 2014, Tella Pharma, Inc. is a Japanese company that manufactures clinical test equipment. The company is based in Tokyo, Japan. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Titan, Inc. (Japan)
![]() Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Technology Services |
Tella Pharma, Inc.
![]() Tella Pharma, Inc. Medical SpecialtiesHealth Technology Founded in 2014, Tella Pharma, Inc. is a Japanese company that manufactures clinical test equipment. The company is based in Tokyo, Japan. | Health Technology |
tella, Inc.
![]() tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |